Alector

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alector and other ETFs, options, and stocks.

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. 

CEO
Arnon Rosenthal
CEOArnon Rosenthal
Employees
103
Employees103
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2013
Founded2013
Employees
103
Employees103

ALEC Key Statistics

Market cap
239.26M
Market cap239.26M
Price-Earnings ratio
-1.77
Price-Earnings ratio-1.77
Dividend yield
Dividend yield
Average volume
466.93K
Average volume466.93K
High today
$2.20
High today$2.20
Low today
$2.02
Low today$2.02
Open price
$2.10
Open price$2.10
Volume
154.00K
Volume154.00K
52 Week high
$3.40
52 Week high$3.40
52 Week low
$1.01
52 Week low$1.01

Stock Snapshot

Alector(ALEC) stock is priced at $2.16, giving the company a market capitalization of 239.26M. It carries a P/E multiple of -1.77.

On 2026-05-11, Alector(ALEC) stock traded between a low of $2.02 and a high of $2.20. Shares are currently priced at $2.16, which is +6.7% above the low and -2.0% below the high.

The Alector(ALEC)'s current trading volume is 154K, compared to an average daily volume of 466.93K.

In the last year, Alector(ALEC) shares hit a 52-week high of $3.40 and a 52-week low of $1.01.

In the last year, Alector(ALEC) shares hit a 52-week high of $3.40 and a 52-week low of $1.01.

ALEC News

TipRanks 4d
Alector Establishes $125 Million At-the-Market Offering

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 4d
Alector reports Q1 EPS (21c), consensus (28c)

Reports Q1 revenue $1.05M, consensus $11.03M. “Over the past seven years, we have built a highly differentiated blood-brain barrier platform with the versatilit...

Analyst ratings

38%

of 8 ratings
Buy
37.5%
Hold
37.5%
Sell
25%

People also own

Based on the portfolios of people who own ALEC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.